MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹27,755 Cr | ₹27,652 Cr | ₹11,883 Cr | ₹9,686 Cr | ₹9,108 Cr |
What is the latest Total Liabilities ratio of MANKIND PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹27,755 Cr |
| Mar2025 | ₹27,652 Cr |
| Mar2024 | ₹11,883 Cr |
| Mar2023 | ₹9,686 Cr |
| Mar2022 | ₹9,108 Cr |
How is Total Liabilities of MANKIND PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹27,755 Cr | 0.37 | |
| Mar2025 | ₹27,652 Cr | 132.70 | |
| Mar2024 | ₹11,883 Cr | 22.68 | |
| Mar2023 | ₹9,686 Cr | 6.34 | |
| Mar2022 | ₹9,108 Cr | - | |
Compare Total Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹100,138.0 Cr | -0.3% | -4.2% | -7.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | -0.3% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 3.1% | 18.9% | 33.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -1.5% | -1.6% | 35.6% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | -0.9% | 1.6% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2% | -3.8% | -0.7% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.3% |
-4.2% |
-7.3% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses